Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ventures Opportunities Fund I. General Partner Llc Flagship currently holds 5,380,500 shares of Evelo Biosciences, Inc. (EVLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures Opportunities Fund I. General Partner Llc Flagship has been a net buyer of EVLO stock. They have purchased $61.5M and sold $0 worth of shares.
Ventures Opportunities Fund I. General Partner Llc Flagship's most recent insider trade was on Oct 13, 2022, when they purchased 914,634 shares at $1.64 per share.
Ventures Opportunities Fund I. General Partner Llc Flagship serves as Executive at Evelo Biosciences, Inc. (EVLO). They have executed 35 insider transactions totaling $61.5M over their tenure at the company.
Ventures Opportunities Fund I. General Partner Llc Flagship holds the position of Executive at Evelo Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Ventures Opportunities Fund I. General Partner Llc Flagship has shown a buying trading pattern, with $61.5M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ventures Opportunities Fund I. General Partner Llc Flagship was on May 13, 2019, when they purchased $10.0M worth of AXLA shares. This transaction involved 500,000 shares at $20.00 per share.
Ventures Opportunities Fund I. General Partner Llc Flagship currently owns 5,380,500 shares of Evelo Biosciences, Inc. (EVLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ventures Opportunities Fund I. General Partner Llc Flagship's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ventures Opportunities Fund I. General Partner Llc Flagship has 35 Form 4 filings on record as an insider at Evelo Biosciences, Inc..
Set alerts for Ventures Opportunities Fund I. General Partner Llc Flagship and 40,000+ other insiders.